Scimeca Dario sold 2,821 shares of PRECISION BIOSCIENCES INC at $9.75 for −$27.5k on Nov 10, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Legal Officer
Chief Legal Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$27,504.75Shares × reported price
Shares traded
2,821Common Stock
Price per share
$9.75Reported price. Read footnotes for ranges.
% of reported position traded
4.73%This security and ownership context
Holdings after
56,782Direct
Trade date
Nov 10, 2026Sell
Filed
Nov 12, 2026, 4:11 PM ET2-day reporting delay
Accession
0001628280-26-073391Code S · Transaction 398826
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 59,603 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

DTIL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
DTIL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −9.7%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. F2: Sale prices for the transactions reported range from $9.60 to $9.845. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3: Includes 3,146 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $3.61.